Pulse Biosciences (PLSE) Cash from Operations (2020 - 2025)

Pulse Biosciences has reported Cash from Operations over the past 6 years, most recently at 14755000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 14755000.0 for Q4 2025, down 61.36% from a year ago — trailing twelve months through Dec 2025 was 54122000.0 (down 48.92% YoY), and the annual figure for FY2025 was 54122000.0, down 48.92%.
  • Cash from Operations for Q4 2025 was 14755000.0 at Pulse Biosciences, down from 13039000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PLSE hit a ceiling of 6570000.0 in Q1 2023 and a floor of 16366000.0 in Q2 2021.
  • Median Cash from Operations over the past 5 years was 11159500.0 (2021), compared with a mean of 11230800.0.
  • Biggest five-year swings in Cash from Operations: tumbled 106.15% in 2021 and later skyrocketed 57.87% in 2023.
  • Pulse Biosciences' Cash from Operations stood at 12694000.0 in 2021, then surged by 37.25% to 7965000.0 in 2022, then rose by 14.85% to 6782000.0 in 2023, then plummeted by 34.83% to 9144000.0 in 2024, then crashed by 61.36% to 14755000.0 in 2025.
  • The last three reported values for Cash from Operations were 14755000.0 (Q4 2025), 13039000.0 (Q3 2025), and 12807000.0 (Q2 2025) per Business Quant data.